Table 3. Odds ratios for LSIL and HSIL risk according to quartile of the serum folate in the control group.
Serum folate |
LSIL |
HSIL |
||||||
---|---|---|---|---|---|---|---|---|
N | Crude OR (95% CI) | Adjusted OR (95% CI)a | P-trendb | N | Crude OR (95% CI) | Adjusted OR (95% CI)a | P-trendb | |
>22.04 | 39 | Reference | Reference | 0.00 | 10 | Reference | Reference | 0.00 |
18.20–22.04 | 40 | 1.02 (0.63–1.64) | 1.01 (0.62–1.64) | 21 | 2.08 (0.96–4.52) | 1.82 (0.83–4.02) | ||
14.13–18.20 | 75 | 1.91 (1.25–2.94) | 1.85 (1.20–2.86) | 33 | 3.29 (1.58–8.83) | 3.28 (1.55–6.92) | ||
⩽14.13 | 93 | 2.36 (1.56–3.59) | 2.30 (1.51–3.52) | 61 | 6.05 (3.02–12.10) | 5.28 (2.60–10.73) |
Abbreviations: LSIL, low-grade squamous intraepithelial lesions; HSIL, high-grade squamous intraepithelial lesions; OR, odds ratio; CI, confidence interval.
Adjusted for age, education level, annual income, spouse smoking, age at menarche, menopause, age at first intercourse, gravidity, intrauterine device and hrHPV infection.
Obtained from trend χ2 test.